OPKO Health, Inc. has agreed to sell its BioReference Health assets for $722 million.

OPK · OPKO Health, Inc.

The AI's read

The cash could give OPKO more room to fund its business, but the filing does not say what OPKO plans to do with it. OPKO also gives up the testing assets and related operations. Some payment depends on closing adjustments, and extra cash depends on future 4Kscore sales. Required approvals still have to be met. The filing gives no sales or profit figures for the assets being sold, so the deal does not show a clear change in OPKO’s outlook.